199 related articles for article (PubMed ID: 16790761)
1. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.
Meli DN; Coimbra RS; Erhart DG; Loquet G; Bellac CL; Täuber MG; Neumann U; Leib SL
Infect Immun; 2006 Jul; 74(7):3890-6. PubMed ID: 16790761
[TBL] [Abstract][Full Text] [Related]
2. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Muri L; Le ND; Zemp J; Grandgirard D; Leib SL
J Neuroinflammation; 2019 Jul; 16(1):156. PubMed ID: 31351490
[TBL] [Abstract][Full Text] [Related]
3. Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis.
Muri L; Perny M; Zemp J; Grandgirard D; Leib SL
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061158
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
Muri L; Grandgirard D; Buri M; Perny M; Leib SL
J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor necrosis factor-alpha in sensorineural hearing loss after bacterial meningitis.
Aminpour S; Tinling SP; Brodie HA
Otol Neurotol; 2005 Jul; 26(4):602-9. PubMed ID: 16015154
[TBL] [Abstract][Full Text] [Related]
6. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.
Perny M; Roccio M; Grandgirard D; Solyga M; Senn P; Leib SL
J Neurosci; 2016 Jul; 36(29):7740-9. PubMed ID: 27445150
[TBL] [Abstract][Full Text] [Related]
7. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis.
Echchannaoui H; Leib SL; Neumann U; Landmann RM
BMC Infect Dis; 2007 Apr; 7():25. PubMed ID: 17428319
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies of pneumococcal meningitis.
Brandt CT
Dan Med Bull; 2010 Jan; 57(1):B4119. PubMed ID: 20175949
[TBL] [Abstract][Full Text] [Related]
10. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.
Grandgirard D; Burri M; Agyeman P; Leib SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4289-95. PubMed ID: 22644021
[TBL] [Abstract][Full Text] [Related]
12. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
[TBL] [Abstract][Full Text] [Related]
13. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Grandgirard D; Schürch C; Cottagnoud P; Leib SL
Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
[TBL] [Abstract][Full Text] [Related]
15. Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis.
Demel C; Hoegen T; Giese A; Angele B; Pfister HW; Koedel U; Klein M
J Neuroinflammation; 2011 Jan; 8(1):7. PubMed ID: 21261959
[TBL] [Abstract][Full Text] [Related]
16. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Brain Pathol; 2003 Apr; 13(2):123-32. PubMed ID: 12744466
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis.
Grandgirard D; Oberson K; Bühlmann A; Gäumann R; Leib SL
Antimicrob Agents Chemother; 2010 Mar; 54(3):1323-6. PubMed ID: 20065062
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
Liechti FD; Grandgirard D; Leppert D; Leib SL
Infect Immun; 2014 Apr; 82(4):1710-8. PubMed ID: 24491581
[TBL] [Abstract][Full Text] [Related]
19. Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone.
Barichello T; Goncalves JC; Generoso Jda S; Simoes LR; Tashiro MH; Goularte Jde A; Vuolo F; Rodrigues DH; Vilela MC; Petronilho F; Teixeira AL; Quevedo J
Curr Neurovasc Res; 2014; 11(3):210-22. PubMed ID: 24845856
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.
Högen T; Demel C; Giese A; Angele B; Pfister HW; Koedel U; Klein M
Antimicrob Agents Chemother; 2013 Oct; 57(10):4825-30. PubMed ID: 23877681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
